{"cik":1894525,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"APIMEDS PHARMACEUTICALS US, INC.","units":{"USD":[{"end":"2025-12-31","val":187395,"accn":"0001213900-26-051139","fy":2025,"fp":"FY","form":"10-K","filed":"2026-05-04"},{"end":"2025-12-31","val":187395,"accn":"0001213900-26-061013","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26"},{"end":"2025-12-31","val":187395,"accn":"0001213900-26-090120","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-14","frame":"CY2025Q4I"},{"end":"2026-03-31","val":171779,"accn":"0001213900-26-061013","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26","frame":"CY2026Q1I"},{"end":"2026-06-30","val":156162,"accn":"0001213900-26-090120","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-14","frame":"CY2026Q2I"}]}}